Tighter regulations and an influx of federal money in recent years have helped communities across the U.S. initiate efforts to clean up lead contamination in soil, drinking water, and older homes. But Congress and the Trump administration have partially rolled back those rules and resources, potentially making it more challenging for cash-strapped cities and towns…
Letters to the Editor is a periodic feature. We welcome all comments and will publish a selection. We edit for length and clarity and require full names. We Have Invested Too Much To Let Research Programs Die Quietly I have dedicated my life to research, but now that work, along with the trust, data, and progress behind it,…
From a recent paper by Nasseh et al. 2026 in Health Services Research: Following acquisition, private equity-owned dental offices increased charges for dental care services by 3.3% (95% CI: 2.3%–4.4%), although allowed prices for these services remained statistically unchanged. Dental offices acquired by private equity firms tended to shift from diagnostic and preventive procedures to…
Healthcare AI customers are demanding clear, measurable ROI before they scale adoption. Here, four investors discussed how the healthcare AI startups are adapting to this new market dynamic. The post AI Startups’ ROI Reckoning: What 4 VCs Say Matters Now appeared first on MedCity News.
This collection of charts explores the variation in health spending across the population through an analysis of 2023 Medical Expenditure Panel Survey (MEPS) data.
In this quickbite interview recorded at the Feb 2026 VIVE conference, I am talking with Miriam Paramore. Miriam is building RxUtility, which is helping consumers access the lowest drug prices at the point of dispensing. That means BOTH bringing in all those manufacturers coupons and getting the lowest cash prices. How does it work? Why…
Health tech companies made several major funding announcements in February. Here is a list of some of the biggest funding rounds. The post 5 Notable Health Tech Funding Announcements in February appeared first on MedCity News.
Company President Mike Roaldi discusses expanding Long-Term Services and Supports to all 11 states where Cityblock is operating
Along with the reverse merger, Candid Therapeutics announced $505 million in private financing to support its pipeline of T cell engagers for autoimmune disease. Lead program cizutamig is on track to begin global Phase 2 testing in myasthenia gravis and interstitial lung disease. The post Candid Therapeutics Strikes Up Merger With Rallybio to Advance Its…
Brian Hoberman, M.D., envisions health systems developing deeply curated conversational AI triage